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             Toxoplasma gondii   is a eukaryotic pathogen that 
causes life threatening toxoplasmosis, a condi-
tion which includes encephalitis in immuno-
compromised individuals, such as those suff  ering 
from AIDS and congenital diseases or being 
treated by chemotherapy, upon primary infec-
tion during pregnancy in humans and animals 
(  Montoya and Remington, 2008  ).   T. gondii   is 
an obligate intracellular eukaryotic parasite ca-
pable of proliferating exclusively inside a parasi-
tophorous vacuole, which is formed during host 
cell invasion (  Joynson and Wreghitt, 2001  ). 
Taxonomically,   T. gondii   belongs to the phylum 
Apicomplexa, which is defi  ned by the presence 
of an apical complex including secretory organ-
elles (  Dubremetz, 2007  ). Among them, the 
large bulb-shaped organelles called rhoptries 
contain a variety of proteins, which are secreted 
into the host cytoplasm or in the forming para-
sitophorous vacuole during parasite entry to 
co-opt the host cell for growth and survival 
(  Boothroyd and Dubremetz, 2008  ). 
  The host initiates a broad range of immune 
responses upon   T. gondii   infection. When in-
fected by   T. gondii  , cells belonging to the innate 
immunity system, such as macrophages and 
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  Infection by   Toxoplasma gondii   down-regulates the host innate immune responses, such as 
proinfl  ammatory cytokine production, in a Stat3-dependent manner. A forward genetic 
approach recently demonstrated that the type II strain fails to suppress immune responses 
because of a potential defect in a highly polymorphic parasite-derived kinase, ROP16. We 
generated ROP16-defi  cient type I parasites by reverse genetics and found a severe defect 
in parasite-induced Stat3 activation, culminating in enhanced production of interleukin (IL) 
6 and IL-12 p40 in the infected macrophages. Furthermore, overexpression of ROP16 but 
not ROP18 in mammalian cells resulted in Stat3 phosphorylation and strong activation of 
Stat3-dependent promoters. In addition, kinase-inactive ROP16 failed to activate Stat3. 
Comparison of type I and type II ROP16 revealed that a single amino acid substitution in 
the kinase domain determined the strain difference in terms of Stat3 activation. Moreover, 
ROP16 bound Stat3 and directly induced phosphorylation of this transcription factor. These 
results formally establish an essential and direct requirement of ROP16 in parasite-induced 
Stat3 activation and the signifi  cance of a single amino acid replacement in the function of 
type II ROP16. 
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  RESULTS 
  Defective Stat3 activation in rop16 KO type I parasite-
infected cells 
  To examine the physiological role of ROP16 in the type I 
strain, rop16 KO parasites were generated by targeted gene 
disruption. The targeting vector contained fl  anking sequences 
of the   ROP16   gene and the entire coding region of ROP16 
was replaced with the   hxgprt   gene (  Fig. 1 A  ).   Upon selection 
for mycophenolic acid (MPA)/xanthine-resistant and yellow 
fl  uorescent protein (YFP)–negative parasites, we isolated two 
homologous recombinant mutants out of 47 clones (  Fig. 1 B  ). 
Northern blot analysis confi  rmed that transcription of  ROP16   
messenger RNA in both mutant clones was completely abol-
ished (  Fig. 1 C  ). Intracellular replication of rop16 KO type I 
parasites in Vero cells and mouse embryonic fibroblasts 
(MEFs) was similar to that of WT parasites (unpublished 
data). Given the previous implication of ROP16 in the strain-
dependent IL-12 p40 production and Stat3 activation (  Saeij 
et al., 2007  ), we fi  rst assessed the eff  ect of ROP16 defi  ciency 
in type I parasites on the parasite-induced proinfl  ammatory 
cytokine production in mouse peritoneal macrophages 
(  Fig. 1 D  ). Compared with WT (  hxgprt  -negative parental 
parasites) or   hxgprt  -positive control type I parasites, produc-
tion of proinfl  ammatory cytokines, such as IL-6 and IL-12 
p40, was dramatically increased in macrophages infected by 
rop16 KO parasites. Stat3 activation has been shown to sup-
press proinfl  ammatory cytokine production in cells infected 
with type I, but not type II, parasites (  Kim et al., 2006  ). There-
fore, we examined parasite-induced Stat3 activation in peri-
toneal macrophages or MEFs. Phosphorylation of Tyr705 on 
Stat3 was observed in cells infected with WT and control 
type I parasites in a time-dependent manner (  Fig. 1 E  ;   Fig. S1, 
A and B  ). In contrast, Stat3 phosphorylation of Tyr705 was 
almost absent in type I rop16 KO parasite-infected cells. 
Moreover, phosphorylation of Stat3 on Ser727, another Stat3 
phosphorylation site which has been previously shown to 
play an important role in full activation of the transcription 
factor (  Ihle, 2001  ), was not induced by parasite infection 
(  Fig. 1 E  ). Collectively and as previously predicted (  Saeij 
et al., 2006  ,   2007  ), these results demonstrate that ROP16 is 
indeed the determinant for the strain diff  erence between type 
II and I (or III) with respect to Stat3 activation. 
  Activation of Stat3 in mammalian cells ectopically 
expressing ROP16 
  To explore the mechanism of ROP16-regulated Stat3 activa-
tion, we constructed vectors containing the ROP16 protein, 
lacking the N-terminal signal peptide, to enable expression in 
mammalian cells. The 293T cells were transfected with ex-
pression vectors for ROP16 or another rhoptry kinase family 
protein, ROP18, also lacking the N-terminal signal peptide. 
We then ectopically expressed these proteins and analyzed 
the eff  ects on Stat3 phosphorylation. Strikingly, the overex-
pression of ROP16, but not ROP18, in 293T cells led to 
high levels of Stat3 phosphorylation of Tyr705 but not Ser727 
(  Fig. 2 A  ).   Furthermore, indirect immunofluorescence 
dendritic cells, produce a set of proinfl  ammatory cytokines, 
including IL-6, IL-12 p40, and nitric oxide, to induce the 
adaptive immune response or to directly eliminate the parasites 
(  Denkers, 2003  ;   Yap et al., 2006  ). In particular, toll-like re-
ceptor (TLR)–mediated MyD88-dependent innate and adap-
tive immune responses have been shown to be essential for the 
host defense against   T. gondii   (  Gazzinelli et al., 2004  ). Recently, 
TLR11 has been shown to recognize the   T. gondii   profi  lin-
like protein, resulting in the production of proinfl  ammatory 
cytokine IL-12 by dendritic cells (  Yarovinsky et al., 2005  ; 
  Yarovinsky and Sher, 2006  ;   Plattner et al., 2008  ). In addition 
to TLR11, TLR2 has also been implicated in parasite-induced 
immune responses (  Scanga et al., 2002  ;   Mun et al., 2003  ;   Del 
Rio et al., 2004  ). In contrast,   T. gondii  –derived cyclophilin, 
C-18, has been shown to activate dendritic cells to produce 
IL-12 through a G protein–coupled chemokine receptor CCR5 
in a TLR-independent fashion (  Aliberti et al., 2003  ). This sug-
gests that both TLR-dependent and -independent innate 
immune responses play important roles in the host defense 
against this parasite. 
    T. gondii   is generally divided into three predominant clonal 
lineages (types I, II, and III) in addition to exotic strains 
(  Ajzenberg et al., 2004  ). These clonal lineages correlate with 
diff  erences in TLR-MyD88–dependent responses to   T. gondii   
(  Aliberti et al., 2003  ;   Denkers et al., 2003  ;   Robben et al., 2004  ; 
  Kim et al., 2006  ). Compared with type I parasites, infection by 
type II parasites results in up-regulation of IL-12 p40 produc-
tion in macrophages. The IL10-independent Stat3 activation, 
induced upon type I parasite infection, was previously shown 
to be defective in type II parasites (  Butcher et al., 2005  ). A 
subsequent study involving a forward genetic approach, in which 
type II and III strains were intercrossed, identifi  ed a highly 
polymorphic rhoptry protein, ROP16, as a candidate gene 
product responsible for Stat3 activation. The introduction of 
type I ROP16 into type II parasites successfully induced pro-
longed Stat3 activation and suppression of IL-12 production 
(  Saeij et al., 2006  ,   2007  ). However, the molecular mechanism 
by which ROP16 regulates Stat3 activation, leading to sup-
pression of innate immune responses, and the basis for the 
strain diff  erences between type I (or III) and II ROP16-
dependent Stat3 activation are not understood. 
  In this paper, we have analyzed the physiological function 
of ROP16 by generating type I ROP16-defi  cient (rop16 KO) 
parasites. Stat3 activation is severely reduced in cells infected 
by type I rop16 KO parasites, leading to an up-regulation of 
IL-6 and IL-12 p40 production compared with cells infected 
by WT parasites. In addition, ectopic expression of ROP16 in 
mammalian cells dramatically increases Stat3 activation. Using 
an in vitro assay system, we demonstrate that the kinase activity 
of ROP16 is essential for Stat3 activation and that a single 
amino acid replacement resulting from the polymorphism be-
tween type I and II is responsible for the strain diff  erence in 
terms of ROP16-regulated Stat3 activation. Furthermore the 
N-terminal portion of ROP16 interacts with Stat3 and ROP16 
directly phosphorylates Stat3 tyrosine 705, indicating the direct 
and essential role of ROP16 in Stat3 activation. JEM VOL. 206, November 23, 2009 
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    Figure 1.     Loss of ROP16 in type I parasites severely impairs Stat3 activation.   (A) The structure of the   ROP16   gene, the targeting vector and the 
predicted disrupted gene. Black boxes denote the exons. (B) Southern blot analysis of offspring from WT or two lines of ROP16-defi  cient parasites. 30 μg 
of total genomic DNA was extracted from parasites, digested with NcoI–BamHI, electrophoresed, and hybridized with the radiolabeled probe indicated in 
A. Southern blotting gave a single 3.5-kb band for WT and a 7.0-kb band for the disrupted locus. (C) Northern blot analysis on 10 μg of a total parasite 
RNA separated on gel, transferred to a nylon membrane, and hybridized with ROP16 probe. 28S and 18S ribosomal RNA was shown as the loading control 
(bottom). (D) Peritoneal macrophages from C57BL/6 mice were cultured with the indicated MOI of parasites in the presence of 30 ng/ml IFN-     for 24 h. 
Concentrations of IL-6 and IL-12 p40 in the culture supernatants were measured by ELISA. Indicated values are means ± SD of triplicates. (E) Serum-
starved peritoneal macrophages were infected with MOI = 10 of indicated parasites for 3 h. Activation of Stat3 was also determined by Western blot of 
cell extracts using anti–phospho-Stat3 Tyr705 or Ser727. Stat3 and actin levels are shown as loading controls. Data are representative of at least three 
(D) or two (B, C, and E) independent experiments.     2750 Direct Stat3 activation by   T. gondii   ROP16   | Yamamoto et al. 
a luciferase assay using reporters harboring Stat3-dependent 
promoters (  Fig. 2 C  ). The presence of ROP16 caused the 
activation of luciferase when controlled by a WT Stat3-
dependent promoter but not by a promoter mutated in the 
analysis revealed that the ectopic expression of ROP16, but 
not ROP18, induced the nuclear translocation of Stat3 (  Fig. 2 B   
and   Fig. S2A  ), suggesting that ROP16 overexpression medi-
ates Stat3 activation. To investigate this further, we performed 
  Figure 2.    Ectopic expression of ROP16 potentiates Stat3 activation in mammalian cells.   (A) 293T cells were transfected with indicated expres-
sion vectors. 48 h after transfection, the cells were lysed and subjected to Western blotting. Activation of Stat3 was also determined by Western blot 
analysis of cell extracts using anti–phospho-Stat3 Tyr705 or Ser727. Stat3 and actin levels are shown as loading controls. Arrows indicate cells immuno-
stained with anti-Flag in the top left and are placed at the same positions in the other photographs. (B) 293T cells were transfected with Flag-tagged 
ROP16 expression vectors. 48 h after transfection, the cells were fi  xed and stained with anti-STAT3 or anti-Flag, and then Alexa Fluor 488–conjugated 
anti–mouse IgG (green), Alexa Fluor 594–conjugated anti–rabbit IgG antibody (red), or DAPI (blue). Bars, 10 μm. (C) 293T cells were transfected with indi-
cated Stat3-dependent luciferase reporters together with either indicated amounts (left) or 1 μg (right) Flag-tagged ROP16 or empty expression vectors. 
As a positive control, cells were treated with 100 ng/ml human leukemia inhibitory factor (LIF) for 12 h (right). Luciferase activities were expressed as fold 
increases over the background level shown by lysates prepared from mock-transfected cells. Indicated values are means ± the variation range of dupli-
cates. Data are representative of at least three (A and C) or two (B) independent experiments.     JEM VOL. 206, November 23, 2009 
Article
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Stat3-binding sites. When APRF-luc, another Stat3-depen-
dent luciferase reporter, was used, the ROP16-mediated ac-
tivation was even more prominent. ROP16 has been shown 
to possess a nuclear localization signal (NLS;   Saeij et al., 
2007  ). When WT or NLS-mutated ROP16 expression vec-
tors were introduced in 293T cells, Stat3 was activated in 
cells transduced with NLS-mutated as well as WT ROP16 
(Fig. S2 B). This was in agreement with a previous fi  nding 
that the NLS of ROP16 is not required for Stat3 and Stat6 
activation (  Saeij et al., 2007  ). Together, these results demon-
strated that the cytosolic expression of ROP16 in mammalian 
cells is suffi   cient to functionally activate Stat3. 
  Kinase activity of ROP16 is essential for Stat3 activation 
  Although the kinase activity of ROP18 has been shown to be 
essential for the virulence of type III parasites (  Saeij et al., 
2006  ;   Taylor et al., 2006  ), the biological signifi  cance of the 
kinase activity of ROP16 remains unclear. To address this 
point, we fi  rst constructed a kinase-inactive mutant of ROP16 
(ROP16  D539A  ) and expressed it in 293T cells to determine 
whether the kinase activity of ROP16 plays an important 
role in Stat3 activation (  Fig. 3 A  ).   In contrast to the strong 
activation of the Stat3-dependent promoters in WT ROP16-
transduced cells, activation of Stat3-dependent promoters 
was not detected in ROP16  D539A  -transfected cells. In addi-
tion, and unlike WT ROP16, ROP16  D539A   failed to induce 
Stat3 Tyr705 phosphorylation (  Fig. 3 B  ). To assess the im-
portance of the ROP16 kinase activity under physiological 
conditions, we performed a functional complementation of 
rop16 KO parasites with either WT ROP16 (ROP16WT) 
or ROP16  D539A   (ROP16KD) containing the N-terminal sig-
nal peptide (  Fig. S3 A  ). Whereas parasites complemented 
with ROP16WT parasites provoked a signifi  cant Stat3 phos-
phorylation in the MEFs, this eff  ect was completely abolished 
in cells infected with ROP16KD parasites (  Fig. 3 C  ). Fur-
thermore,   T. gondii  –induced IL-6 and IL-12 p40 production 
was severely reduced when macrophages were infected with 
ROP16WT but not with ROP16KD or control parasites 
(  Fig. 3 D  ). Collectively, these results suggested that the kinase 
activity of ROP16 plays a pivotal role in the function of 
ROP16 in terms of Stat3 activation and suppression of pro-
infl  ammatory cytokine production. 
  A single amino acid polymorphism in ROP16 determines 
its Stat3-activating potency 
  ROP16 is highly polymorphic between type I (or III) and II 
parasites (  Saeij et al., 2006  ,   2007  ). Given that the relative ex-
pression levels among the three strains from the quantitative 
RT-PCR data deposited in ToxoDB are similar (unpub-
lished data), the polymorphism might be responsible for the 
defective Stat3 activation in cells infected with type II para-
sites. However, the precise molecular mechanism involved 
remains to be elucidated. To address this issue, we cloned 
type II (ME49)   ROP16   complementary DNA from a type II 
strain, ME49, into a mammalian expression vector. In 293T 
cells expressing ME49 ROP16, activation of the Stat3-
dependent promoters was only slightly induced, as compared 
with cells expressing kinase-inactive ROP16  D539A  . However, 
it was dramatically lower compared with cells expressing type 
I (RH) ROP16, indicating that potency of ME49 ROP16 in 
Stat3 activation may be profoundly but not totally impaired 
(  Fig. 4 A  ).   Next, to identify which regions of the ME49 
ROP16 protein are responsible for the defective Stat3 activa-
tion, a series of chimeric ROP16 constructs were generated. 
Domains of ROP16 were swapped between RH and ME49 
ROP16, taking advantage of the presence of conserved re-
striction enzyme sites, and the resulting chimeras were as-
sessed for Stat3 activation in 293T cells (  Fig. 4 B  ). The results 
revealed a severe defect in Stat3 activation conferred by re-
placement of the central domain R2 in RH ROP16 with 
M2 of ME49 ROP16. This region exhibits nine polymor-
phic amino acid substitutions, and each of them were re-
placed in RH ROP16 with the corresponding sequence of 
ME49 and tested for Stat3-dependent reporter activation 
(  Saeij et al., 2007  ;   Fig. S4  ). Among them, the substitution of 
a leucine residue at position 503 to a serine (L503S) located 
in the kinase domain resulted in a dramatic decrease in Stat3 
activation to a level comparable to that mediated by ME49 
ROP16 (  Fig. 4 C  ). Next, we assessed whether the single re-
verse mutation of the serine residue at position 503 to a leu-
cine (S503L) in ME49 ROP16 restored Stat3 activation. We 
found that ME49 ROP16 S503L resulted in full restoration 
of Stat3 activation (  Fig. 4 D  ). These fi  ndings indicated that a 
single amino acid of ROP16 may determine the strain diff  er-
ence between RH and ME49 strains. Finally, we generated 
transgenic parasite strains expressing WT or L503S-type RH 
ROP16 (RH  WT   or RH  L503S  , respectively) or WT or S503L-
type ME49 ROP16 (ME49  WT   or ME49  S503L  , respectively) in 
rop16 KO parasites to assess their Stat3 activation in vivo 
(Fig. S3 B). In perfect agreement with a previous observation 
(  Saeij et al., 2007  ), Stat3 activation, as measured by phos-
phorylation, was significantly increased by RH  WT   and 
ME49  S503L   and induced, but markedly reduced, by RH  L503S   
or ME49  WT   (  Fig. 4 E  ). These results indicate that WT ME49 
(type II) ROP16 and L503S-type RH (type I) ROP16 mu-
tants are impaired but not completely defective in Stat3 acti-
vation in vivo. Collectively, these results clearly demonstrated 
that the single amino acid polymorphism at position 503 in 
ROP16 determines the strain diff  erence between type I and 
II strains in terms of Stat3 activation. 
  Direct Stat3 activation by ROP16 
  Regarding the molecular basis of ROP16-mediated Stat3 ac-
tivation, a previous fi  nding suggested that ROP16 may indi-
rectly activate Stat3, based on Stat3 phosphorylation in the 
very early time points of infection (  Saeij et al., 2007  ). Indeed, 
as observed for 293T cells, when we infected MEFs with 
transgenic parasites expressing type I or type II ROP16, and a 
parental line, we observed moderate Stat3 phosphorylation in 
cells infected with type II ROP16-expressing parasites, albeit 
signifi   cantly reduced compared with that induced by the 
infection of type I ROP16-expressing parasites. In sharp 2752 Direct Stat3 activation by   T. gondii   ROP16   | Yamamoto et al. 
    Figure 3.     The kinase activity of ROP16 is essential for Stat3 activation.   (A) 293T cells were transfected with the indicated Stat3-dependent lucif-
erase reporters together with indicated amounts of Flag-tagged WT or kinase-inactive ROP16 (ROP16WT or ROP16KD, respectively) or empty expression 
plasmids. Luciferase activities were expressed as fold increases over the background levels shown by lysates prepared from mock-transfected cells. 
(B) 293T cells were transfected with the indicated expression vectors. 48 h after transfection, the cells were lysed and subjected to Western blotting. Acti-
vation of Stat3 was also determined by Western blot analysis of cell extracts using anti–phospho-Stat3. (C) Serum-starved MEFs were infected with an 
MOI = 10 of the indicated parasites for 18 h. Activation of Stat3 was also determined by Western blot analysis of cell extracts using anti–phospho-Stat3 
Tyr 705. Stat3 and actin levels are shown as loading controls. (D) Peritoneal macrophages from C57BL/6 mice were cultured with the indicated MOI of 
parasites in presence of 30 ng/ml IFN-     for 24 h. Concentrations of IL-6 and IL-12 p40 in the culture supernatants were measured by ELISA. Indicated 
values are means ± SD of triplicates. Data are representative of three (A and C), four (B), or two (D) independent experiments.   JEM VOL. 206, November 23, 2009 
Article
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  Figure 4.    The L503S polymorphic mutation in type II ROP16 determines its defective Stat3 activation.   (A–D) 293T cells were transfected with 
the APRE-luc plasmid together with the indicated ROP16 expression vectors. Luciferase activities were expressed as fold increases over the background 
levels shown by lysates prepared from mock-transfected cells. Indicated values are means ± the variation range of duplicates. A list of the chimeric 
ROP16 expression vectors is shown (B, left). R, RH (pink); M, ME49 (blue). (E) Serum-starved MEFs were infected with an MOI = 10 of the indicated para-
sites for 18 h. Activation of Stat3 was also determined by Western blot analysis of cell extracts using anti–phospho-Stat3 Tyr 705. Stat3 and actin levels 
are shown as loading controls. Data are representative of three (A and E) or two (B–D) independent experiments.     2754 Direct Stat3 activation by   T. gondii   ROP16   | Yamamoto et al. 
  Figure 5.    Direct Stat3 activation by ROP16.   (A) Relative Stat3 phosphorylation levels. Serum-starved MEFs were infected with an MOI = 10 of the 
indicated parasites for indicated times. The intensity of Stat3 phosphorylation observed by immunoblotting with anti–phospho-Stat3 antibody was 
quantitated using a phosphoimager and normalized to images of total Stat3, as shown in   Fig. S5  . Each count from which that of the uninfected point was 
subtracted was shown. (B) 293T cells were transiently transfected with Flag-tagged ROP16WT or FLAG kinase–inactive ROP16KD. Cell lysates were 
immunoprecipitated with anti-FLAG and subjected to an in vitro kinase reaction in the presence of GST–Stat3. Proteins were separated on SDS-PAGE, fol-
lowed by Western blotting to analyze Stat3 phosphorylation, GST-Stat3, and Flag-tagged ROP16WT or ROP16KD by anti–phospho-Stat3 (Tyr705), anti-GST, 
and anti-Flag, respectively. (C) Lysates of 293T cells transiently cotransfected with 2 μg Flag-tagged Stat3 and/or 2 μg HA-tagged ROP16WT or ROP16KD JEM VOL. 206, November 23, 2009 
Article
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expression vectors were immunoprecipitated with the indicated antibodies. *, nonspecifi  c bands. (D and E) 293T cells were transfected with the indicated 
Stat3-dependent luciferase reporters together with indicated expression vectors. Luciferase activities were expressed as fold increases over the background 
levels shown by lysates prepared from mock-transfected cells. (F) Lysates of 293T cells transiently cotransfected with 2 μg Flag-tagged Stat3 and/or 2 μg 
HA-tagged ROP16 full-length,     200, or     280 expression vectors were immunoprecipitated with the indicated antibodies. *, nonspecifi  c bands. Indicated 
values are means ± the variation range of duplicates. Data are representative of three (A, C, and E) or two (B, D, and F) independent experiments.     
 
contrast, Stat3 activation in cells infected with rop16 KO para-
sites was nearly abolished (  Fig. 5 A   and   Fig. S5  ), indicating that 
ROP16 might directly activate Stat3.   To challenge this possi-
bility, we next performed an in vitro kinase assay using re-
combinant GST-tagged Stat3 as the substrate. Flag-tagged 
ROP16WT and ROP16KD were expressed in 293T cells 
and cell lysates were immunoprecipitated with anti-Flag. We 
detected phosphorylation of Stat3 Tyr705 in immunoprecipi-
tates of ROP16WT, but not ROP16KD (  Fig. 5 B  ), suggest-
ing that Stat3 is directly phosphorylated by ROP16. Next, the 
interaction of Stat3 with ROP16 was investigated by a series 
of coimmunoprecipitation experiments. 293T cells were tran-
siently transfected with plasmids encoding HA-tagged 
ROP16WT or ROP16KD along with Flag-tagged Stat3. 
HA-tagged WT or kinase-inactive ROP16 were coimmuno-
precipitated with anti-Flag, although relatively less ROP16WT 
was copurifi  ed compared with ROP16KD (  Fig. 5 C  ), indi-
cating the existence of an interaction between ROP16 and 
Stat3. We then examined which regions of ROP16 are re-
quired for the interaction with Stat3. When we transiently 
expressed the C-terminal portion of ROP16 that contained 
only the kinase domain (residues 345–727) in 293T cells, we 
failed to observe activation of the Stat3-dependent promoter 
(  Fig. 5 D   and   Fig. S6  ). We constructed a series of deletion 
mutants of ROP16 (amino acids deleted:     60, 1–63;     140, 
1–143;     220, 1–223; and     300, 1–303) and tested them for 
Stat3 activation (Fig. S6). Overexpression of full-length 
ROP16, and ROP16 deletion mutants     60,     140, and     220, 
but not deletion mutant     300, led to activation of the Stat3-
dependent promoter (  Fig. 5 E  ). We examined the interaction 
of Stat3 with full-length ROP16 and ROP16 deletion mu-
tants     220 and     300. Flag-tagged Stat3 proteins were copre-
cipitated with anti-HA in cells coexpressing HA-tagged 
full-length ROP16 or ROP16 deletion mutant     220, but not 
    300 (  Fig. 5 F  ). Collectively, these results demonstrate that 
the N-terminal region between aa 223 and 303 of ROP16 
may be required for the interaction with Stat3 (Fig. S6). 
  Profi  le of the kinase domain and activity of ROP16 
  Next we built in silico structural models for the kinase do-
mains of ROP16 variants to assess whether ROP16 presents 
the signature of a kinase capable of phosphorylating tyrosine 
residues (  Fig. 6 A  ).   The in silico model of the kinase domain 
of ROP16 was structurally aligned to known kinases and then 
ranked using a combined structure and sequence-profi  le-pro-
fi  le similarity score. This analysis indicated that the highest 
similarity was to dual-specifi  city mitogen-activated protein 
kinase kinases (  Table S1  ). In addition, we compared the ki-
nase domains of RH  WT  , RH  L503S  , ME49  WT  , and ME49  S503L   
to examine the signifi  cance of residue position 503 (  Fig. 6 B   
and   Fig. S7 A  ). These models indicated that residue 503 is 
completely solvent inaccessible and may act to stabilize the 
C-terminal surface of the cavity formed by the N and C-terminal 
subdomains (  Fig. 6 A  ). In addition, we found that both the 
modeled RH  L503S   and ME49  WT   cavities were larger and 
contained lower electrostatic potentials than did RH  WT   or 
ME49  S503L   (  Fig. 6 B   and Fig. S7 A). The corresponding cavity 
has been shown to form the active site in the most similar 
known kinases (  Ohren et al., 2004  ;   Zhao et al., 2007  ; Table S1), 
suggesting that the replacement of leucine with serine in type I 
ROP16 may result in an active site shape that is similar to 
that of type II ROP16. Finally we performed luciferase re-
porter and in vitro kinase assays to characterize the kinase 
activity of ROP16 by kinase inhibitors. 293T cells were trans-
fected with empty or ROP16 expression vectors in the pres-
ence or absence of various kinase inhibitors together with the 
Stat3-dependent luciferase reporter (  Fig. 6 C   and Fig. S7 B). 
Among them, we found that treatment with K-252a severely 
inhibited the ROP16-mediated activation of the Stat3-
dependent promoter (  Fig. 6 C   and Fig. S7 B). Furthermore, 
K-252a treatment markedly reduced in vitro ROP16-medi-
ated phosphorylation (  Fig. 6 D  ). Collectively, these results 
show that the kinase activity of ROP16 is K-252a sensitive 
and that the amino acid substitution of a leucine at position 
503 may aff  ect the active cavity of the kinase domain. 
  DISCUSSION 
  In this study, we fi  rst confi  rmed by reverse genetics that a 
product of   T. gondii ROP16   gene is responsible for Stat3 acti-
vation and suppression of   T. gondii  –induced proinfl  ammatory 
cytokines induced by type I strains. Indeed, disruption of the 
  ROP16   gene in the type I strain converted the parasite into to 
a type II phenotype regarding Stat3 phosphorylation and acti-
vation. Consistent with a direct role played by ROP16, the 
complementation of rop16 KO parasites with type I ROP16, 
but not with type II ROP16, fully rescued the phenotype. 
  In addition, we elucidated the molecular mechanisms 
underlying the strain diff  erence between type I (or III) and II 
ROP16 through an in vitro assay system using mammalian 
cells that allowed us to precisely characterize chimeric and 
site-specifi  c mutants of ROP16 aff  ected in Stat3 activation. This 
led us to the identifi  cation of a crucial polymorphic leucine/
serine residue at position 503 in ROP16 that determines the 
strain diff  erence with respect to Stat3 activation. Further-
more, we demonstrated that ROP16 directly phosphorylates 
Stat3 and that the N-terminal portion of ROP16 is essential 
for ROP16–Stat3 interaction. A previous study showed that 
infection of type II, as well as type I and III, parasites induced 2756 Direct Stat3 activation by   T. gondii   ROP16   | Yamamoto et al. 
  Figure 6.    In silico, in vitro  ,   and in vivo profi  ling of the ROP16 kinase domain.   (A) The molecular surface of the kinase domain of RH  WT  , colored by 
electrostatic potential, with red (or blue) representing the most negative (or positive) values. The active site region is framed by a white box, and the ap-
proximate location of the solvent inaccessible residue 503 is indicated by an arrow. (B) Close-up views of the active site regions, corresponding to the box 
in A, for RH  WT ,  ME49 S503L ,  RH L503S ,  and  ME49 WT  . Top (RH  WT   and  ME49 S503L  ) and bottom (RH  L503S   and  ME49 WT  ) types, distinguished by a dashed line, represent 
high and low potencies for Stat3 activation, respectively. (C) 293T cells were transfected with the APRF-luc reporters together with 1 μg of empty or Flag-
tagged ROP16 (ROP16WT) expression vectors in the presence of 5 μM K-252a or DMSO (control). Luciferase activities were expressed as fold increases JEM VOL. 206, November 23, 2009 
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over the background levels shown by lysates prepared from mock-transfected cells. Indicated values are means ± the variation range of duplicates. 
(D) 293T cells were transiently transfected with Flag-tagged ROP16WT. Cell lysates were immunoprecipitated with anti-FLAG and subjected to an in vitro 
kinase reaction by using GST–Stat3 as the substrate in the presence of 5 μM K-252a or DMSO (control). Proteins were separated on SDS-PAGE, followed 
by Western blotting to analyze Stat3 phosphorylation, GST-Stat3, and Flag-tagged ROP16WT by anti–phospho-Stat3 (Tyr705), anti-GST, and anti-Flag, 
respectively. Data are representative of two independent calculations (A and B) or three independent experiments (C and D).     
 
early Stat3 activation, suggesting that ROP16 may play a role 
in sustaining, but not initiating, Stat3 (and Stat6) activation 
(  Saeij et al., 2007  ). In contrast, our results using rop16 KO 
type I parasites exhibited almost complete loss of Stat3 activa-
tion throughout the time course of infection (Fig. S1 B), in-
dicating that ROP16 may be required for onset, as well as for 
sustaining Stat3 activation. 
  Furthermore, Leu503 in ROP16 might be required for 
sustaining Stat3 phosphorylation at later time points because 
Stat3 phosphorylation decreased more rapidly in cells infected 
with transgenic parasites expressing type II ROP16 than 
those expressing type I ROP16 (  Fig. 5 A   and Fig. S5). Con-
sidering the in silico modeling of RH  WT  , RH  L503S  , ME49  WT  , 
and ME49  S503L  , the amino acid substitution observed in the 
kinase domain of type II ROP16 may distort the active site 
and possibly result in impaired substrate binding, culminating 
in the low capacity for Stat3 activation. However, the formal 
proof of this prediction should be performed by crystallizing 
the structures of the ROP16 variants. Moreover, we showed 
that the NLS on ROP16 was not essential for Stat3 activa-
tion, which is consistent with a previous study (  Saeij et al., 
2007  ). Given that Stat3 phosphorylation presumably occurs 
in the cytoplasm (  Bromberg and Darnell, 2000  ;   Kishimoto, 
2005  ), cytoplasmic, but not nuclear localized, ROP16 may 
be more suitable for Stat3 activation. In addition, evidence 
for an interaction between Stat3 and ROP16 was obtained 
by coimmunoprecipitation experiments in 293T cells. Inter-
estingly, ROP16KD appears to form a more stable inter  action 
with Stat3 than with ROP16WT (  Fig. 5 C  ), possibly because 
it fails to phosphorylate the substrate and, thus, liberate it 
from the catalytic site. 
  Regarding the time scale of Stat3 phosphorylation, the   
T. gondii  –induced activation occurs later than that in response 
to cytokines such as IL-6 or IL-10 (  Montag and Lotze, 2006  ; 
and Fig. S1 B). The disparities between two modes of Stat3 
activation might be a result of the time lag required for the 
parasite to inject suffi   cient amounts of ROP16 for full activa-
tion of Stat3 into host cells, or to the functional insuffi   ciency 
of ROP16 as a tyrosine kinase in comparison to typical Stat3 
kinases such as JAK1 or Src (  Ihle, 2001  ). 
  Another Stat family member, Stat6, is also activated dur-
ing the early phase of   T. gondii   infection (  Saeij et al., 2007  ). 
Activation of Stat3 and Stat6 in the parasite-infected macro-
phages might lead to suppression of IL-12, which is essential 
for the development of Th1-prone immune responses, and to 
diff  erentiation of the infected cells into immune suppressive 
macrophages, respectively (  Mordue and Sibley, 2003  ;   Trinchieri, 
2003  ;   Robben et al., 2005  ;   Sinha et al., 2005  ). Whether 
ROP16 directly phosphorylates Stat6 as well as Stat3 can be 
addressed in the future using the rop16 KO and applying 
similar in vitro assay systems. 
  ROP16 was originally reported to be a serine/threonine 
kinase (PS/TK;   Saeij et al., 2006  ,   2007  ;   El Hajj et al., 2006  ; 
  Dubremetz, 2007  ). Rather unexpectedly, we found that 
Tyr705 of recombinant Stat3 is phosphorylated by ROP16 
in an in vitro kinase assay. Therefore, although there is no 
experimental evidence showing that ROP16 phosphorylates 
the serine or threonine residue of known substrates, ROP16 
might be capable of phosphorylating not only serine/threonine 
but also tyrosine residues. Sequence analysis of the kinase 
domain of ROP16, using the Conserved Domain Search 
Program at the National Center for Biotechnology Informa-
tion database, revealed a rather weak level of conservation 
compared with typical PS/TKs (e.g., e-values for ROP16 
and a typical PS/TK IKK-     are 4e-09 and 4-e52, respec-
tively). Moreover, in silico structural analysis revealed simi-
larity to dual-specifi   city mitogen-activated kinase kinases, 
which are shown to be tyrosine/threonine kinases (  Crews 
et al., 1992  ), for the kinase domain of ROP16. This, along 
with the observation that a tyrosine kinase inhibitor K-252a 
treatment severely impaired the kinase activity of ROP16 for 
Stat3 Tyr705 phosphorylation in in vitro and in vivo assays, 
suggests that ROP16 might potentially present the signature 
of a kinase capable of phosphorylating tyrosine residues (  Fig. 6, 
C and D  ; Table S1). Given that protein tyrosine kinases are 
considered to have originated from within the superfamily of 
PS/TKs during the evolution of sponges (  Kruse et al., 1997  ), 
PS/TKs in protozoa belonging to the phylum Apicomplexa, 
which includes   T. gondii  , might possess the characteristics of 
dual-specifi  c kinases. A structural approach, in which three-
dimensional structures of ROP2 and ROP8 were recently 
resolved (  Qiu et al., 2009  ), might possibly apply to the case 
of ROP16 and lead to the key catalytic site for Stat3 phos-
phorylation in future studies. 
  Collectively, this study establishes that ROP16 directly 
mediates Stat3 phosphorylation and leads to the identifi  cation 
of single amino acid polymorphism in ROP16 that is respon-
sible for its dramatically reduced activity in type II strain. The 
rop16 KO parasites will further assist in uncovering the phys-
iological functions of ROP16 including the biological signif-
icance of the nuclear translocation. 
  MATERIALS AND METHODS 
  Cells, mice, and parasites.     C57BL/6 mice (6–8 wk of age) were obtained 
from SLC. Peritoneal macrophages were collected from peritoneal cavities 96 h 
after 4% thioglycollate injection. All animal experiments were conducted 
with the approval of the Animal Research Committee of Graduate School of 
Medicine in Osaka University. RH    hxgprt and ME49 tachyzoites of   T. gondii   
were maintained on Vero or MEFs by biweekly passage in RPMI (Nacalai 2758 Direct Stat3 activation by   T. gondii   ROP16   | Yamamoto et al. 
CTCTGTAAG-3    ; S458E, 5   -TACAGAGACTGTGGAGCAATACGGT-
CTGC-3     and 5    -GCAGACCGTATTGCTCCACAGTCTCTGTA-3    ; 
F486V, 5    -AGGTTCTCGACTCGTTGTCGTGTCCAA-3     and 5    -TTG-
GACACGACAACGAGTCGAGAACCT-3    ; A502P, 5    -AATTGATG-
GC  TCCCCATTGAACAGTCT-3     and 5    -AGACTGTTCAATGGG  G-
AG  CCATCAATT-3    ; L503S, 5    -GATGGCTCCGCATCGAACAGTCTA-
GTC-3     and 5    -GACTAGACTGTTCGATGCGGAGCCATC-3    ; L525I, 
5    -AAGGGAAGCAATTATTGCATTGGCCAA-3     and 5    -TTGGCC  A-
ATGCAATAATTGCTTCCCTT-3    ; kinase inactive mutant D539A, 5    -GA-
TTCGCGCATGGAGCTGTTAAATTGAACA-3     and 5    -TTGTT  CAA-
TTTAACAGCTCCATGCGCGAAT-3    ; NLS mutant, 5    -GTTGCTGC-
CCGTATGCGGATGAGAATGCAACCTCCAGGAGC-3     and 5   -GC  T-
CCTGGAGGTTGCATTCTCATCCGCAGACGGGCAGCAAC-3    ; and 
S503L type II ROP16, 5    -TGATGGCTCCCCATTGAACAGTCTAG-
TCC-3     and 5    -GGACTAGACTGTTCAATGGGGAGCCATCA-3    . Ex-
pression plasmids were generated using a site-directed mutagenesis kit (Strata-
gene). The sequences of all constructs were confi  rmed with an ABI PRISM 
Genetic Analyzer (Applied Biosystems). Flag-tagged Stat3 expression vector 
(a gift from S. Akira, Osaka University, Suita, Osaka, Japan) was described 
previously (  Minami et al., 1996  ). 
  Generation of transgenic parasites.     To complement the ROP16-
deficient parasites, we generated an N-terminal signal peptide–containing 
ROP16 that was capable of being processed in the parasite by PCR using 
forward primer 5    -GAATTCCCTTTTTCGACAAAAATGAAAGTGAC-
CACGAAAGGGCT-3     and expressed a sag1-TgROP16-HA plasmid con-
taining a pyrimethamine resistant gene cassette in the rop16 KO strain. We 
generated this vector by digesting the pyrimethamine resistance cassette of 
the p2854 plasmid with NotI and XhoI and ligated this into Klenow-treated 
pBluescript sag1-TgROP16-HA vector. A series of TgROP16-HA vectors 
were transfected into tachyzoites of the ROP16-defi  cient parasites. We se-
lected for parasites stably expressing the complemented TgROP16-HA con-
struct using 3-μM pyrimethamine (Sigma-Aldrich) selection and subjected 
to limiting dilution as described in the previous paragraph and previously 
(  Donald et al., 1996  ). 
  Reagents.     Antiphosphorylated Stat3 Tyr705 or Ser727 was purchased from 
Cell Signaling Technology. Anti-actin, GST, Stat3, Toxoplasma p30 anti-
gen, and HA probe were purchased from Santa Cruz Biotechnology, Inc. 
GST-Stat3 was purchased from SignalChem. Anti-Flag was obtained from 
Sigma-Aldrich. Kinase inhibitors (InSolution Casein Kinase II inhibitor I, 
PP2, SB202190, K-252a, PD153035, JAK inhibitor I, Y-27632, and GSK-3 
inhibitor IX) were purchased from EMD. 
  Measurement of proinfl  ammatory cytokine concentrations.     Perito-
neal macrophages were cultured in 96-well plates (1 × 10  5   cells per well) 
with the indicated MOI of the indicated parasites for 24 h. Concentrations 
of IL-6 and IL-12 p40 in the culture supernatant were measured by ELISA 
according to manufacturer’s instructions (eBioscience), as described previ-
ously (  Yamamoto et al., 2004  ). 
  Luciferase reporter assay.     The reporter plasmids were transiently cotrans-
fected into 293T cells with the control Renilla luciferase expression vectors 
using Lipofectamine 2000 reagent (Invitrogen). Luciferase activities of total 
cell lysates were measured using the Dual-Luciferase Reporter Assay System 
(Promega) as described previously (  Yamamoto et al., 2006  ). 
  Western blot analysis and immunoprecipitation.     MEFs, 293T cells, 
and parasites were then lysed in a lysis buff  er containing 0.1% Nonidet-P 40, 
150 mM NaCl, 20 mM Tris-HCl, pH 7.5, and protease inhibitor cocktail 
(Roche). The cell lysates were separated by SDS-PAGE and transferred to 
PVDF membranes. For immunoprecipitation, cell lysates were precleared 
with Protein G–Sepharose (GE Healthcare) for 2 h and then incubated with 
Protein G–Sepharose containing 1.0 μg of the indicated antibodies for 12 h 
with rotation at 4°C. The immunoprecipitants were washed four times with 
Tesque) supplemented with 2% heat-inactivated FCS (JRH Biosciences), 
100 U/ml penicillin, and 0.1 mg/ml streptomycin (Invitrogen). 
  Generation of ROP16-defi   cient type I   T. gondii.       A genomic DNA 
containing the   ROP16   gene was isolated from PCR amplifi  cation using 
primers 5    -GCGGCCGCTGTCTGTCCTTCCATCGGCGTGTATT-3     
and 5    -AGATCTTGCGACAAACAAGATCACAG-3     to generate a 5.0-
kb-long fragment and primers 5    -GTCGACGGTGTAAGGTTCCCACCT-
TAACACC-3     and 5    -CTCGAGATATCAATTAACGCACACTTGAA-
GGTCGC-3     to generate a 1.0-kb-short fragment. The gene encoding 
  T. gondii ROP16   consists of a single exon. The targeting vector was constructed 
by replacing entire coding sequence of   ROP16   gene with the   HXGPRT   
gene expression cassette (p2855). Outside the targeting vector, YFP expres-
sion vector containing the 1.0-kb SAG1 promoter (amplifi  ed using primers 
5    -GAATTCACTCGTCAAAAAACCAGAAGAAA-3     and 5    -CTCGA-
GATGCTTGCGTAGGTTGACCTCTGA-3    ) and the poly A additional 
signal from DHFR gene (sag1-YFP) was ligated using a NotI site for the 
negative selection of random integration (  Mazumdar et al., 2006  ). 100 μg of 
the targeting vector linearized by EcoRV were transfected into tachyzoites 
of the RH    hxgprt parental strain as previously described (  Donald et al., 
1996  ). After 25 μg/ml MPA (Sigma-Aldrich) and 25 μg/ml xanthine (Wako 
Chemicals USA, Inc.) selection for 14 d, MPA/xanthine-resistant colonies 
were sorted using FACSAria (BD) to isolate YFP-negative parasites. Then, 
the MPA/xanthine-resistant and YFP-negative parasites were subjected to 
limiting dilution to isolate the clones. A total of 47 clones were selected and 
screened by PCR for detecting homologous recombinants using primers 
5    -CGGGTTTGAATGCAAGGTTTCGTGCTG-3     (from the DHFR 
promoter of the   HXGPRT   expression vector) and 5    -CAATGGCGCGT-
GTGTGTTCAAAC-3     (genomic sequence outside the short fragment of 
the   ROP16   locus) to detect homologous recombinants. This resulted in iso-
lation of two homologous recombinants. Subsequently, genomic DNA of 
WT and ROP16-defi  ceint parasites was extracted and subjected to Southern 
blot analysis using DNA probe, which was generated by PCR (using primers 
5    -GGAACGTCACCTTAATACGT-3     and 5    -TAAGAGCAAAG  T-
CT  C  CCTAG-3    ). In addition, to confi  rm the disruption of the gene encod-
ing ROP16, we analyzed total RNA from WT and ROP16-defi  cient 
parasites by Northern blotting using a DNA probe, which was generated 
by PCR (using primers 5    -TCTGGAAGAAGTTCAGCAGC-3     and 
5    -C  T  G  TACGGCACCTTCGCTGC-3    ). 
  Mammalian expression plasmids.     Luciferase reporters containing the 
Stat3-dependent promoter constructs (gifts from T. Hirano, Osaka Univer-
sity, Suita, Osaka, Japan) have been previously described (  Nakajima et al., 
1996  ;   Ichiba et al., 1998  ). Fragments of type I and type II ROP16 lacking the 
N-terminal signal peptide (amplifi   ed using the primer 5    -GAATTCAC-
CATGCGATACATGTCGTTTGAG-3     and the common primer 5   -CT  C-
GAGCATCCGATGTGAAAGAAAGTTCGGT-3    ) and the series of 
type I ROP16 fragments (amplifi   ed using the following primers:     60, 
5    -GAA  TT  CACCATGGGGTCTCCTACGGCAGGGCAACCT-3    ;     140, 
5    -GAA  TTCACCATGGGACCGGGAGGATGGTTTCCAACA-3    ;     220, 
5    -GA  A  TTCACCATGAATCCTCTTTTTCCTGGTCAGAGC-3    ;     300, 
5    -GAA  TTCACCATGCAGCTGAAAGCAGCTGCCGCACAG-3    ; and 
    N, 5    -GAATTCACCATGCAACCTCCAGGAGCGGTGGAG-3    ) and 
the common primer were obtained by PCR using genomic DNA from RH 
strain (type I) or ME49 (type II) and were ligated into the EcoRI and XhoI 
sites of pcDNA (Invitrogen) for expression of HA- or Flag-tagged proteins. 
Flag-tagged full-length ROP18 was obtained by PCR using the primers 
5    -GGATCCACCACCATGGGTTTAGCGACTCTT-3     and 5    -GCGGC-
CGCTACTTGTCATCGTCGTCCTTGTAGTCTTCTGTGTGGAGA-
TGT-3     and genomic DNA of RH strain as template and were ligated into 
the BamHI and NotI sites of pcDNA vector. A series of type I ROP16 mu-
tants containing point mutations were generated using the following primers: 
G424E, 5   -GAACTGGAGGCGGAAATTTCCTCAGCT-3     and 5   -AGC-
TGAGGAAATTTCCGCCTCCAGTTC-3    ; V457A, 5    -CTTACAG  AGA-
CTGCGAGCCAATACGGT-3     and 5    -ACCGTATTGGCTCGCAGT-JEM VOL. 206, November 23, 2009 
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of kinase inhibitors. Table S1 provides a list of the 20 most similar kinases 
to the RH  WT   mode using the Spanner model built from SCOP domain 
d1s9jA. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20091703/DC1. 
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lysis buff  er, eluted by boiling with Laemmli sample buff  er, and subjected to 
Western blot analysis using the indicated antibodies earlier in this paragraph 
and previously (  Yamamoto et al., 2003  ). 
  In vitro kinase assay.     293T cells were transiently transfected with a total 
of 4.0 μg of either empty vector or the indicated plasmids (4 μg Flag-tagged 
ROP16WT or ROP16KD), using Lipofectamine 2000 as specifi  ed by the 
manufacturer (Invitrogen). Cells were harvested 48 h after transfection, 
lysed, and then immunoprecipitated with protein G–Sepharose together 
with 1.0 μg of anti-FLAG M2 mAb (Sigma-Aldrich) for 12 h by rotation. 
The beads were washed four times with lysis buff  er, and another three times 
with kinase assay buff  er (30 mM MOPS, pH 7.5, 50 mM NaCl, 10% glyc-
erol, 10 mM MgCl  2  , and 10 mM MnCl  2  ). The immunoprecipitates were 
incubated with 1 μg GST-Stat3 and 5 μM ATP (Wako Chemicals USA, 
Inc.) to detect specifi  cally phospho-Stat3 Tyr705 at 30°C for 30 min in the 
absence (  Fig. 5 B  ) or presence (  Fig. 6 C  ) of DMSO or K-252a. Kinase reac-
tions were stopped by addition of Laemmli sample buff  er and were separated 
on a 5–20% poly acrylamide gradient gel. Gel was detained and subjected to 
Western blot analysis to detect phospho-Stat3, GST-tagged Stat3, and Flag-
tagged ROP16WT or ROP16KD by anti–phospho-Stat3 Tyr705, anti-
GST, and anti-Flag, respectively. 
  Microscopic analysis.     293T cells were transfected with 2 μg Flag-tagged 
ROP16 or ROP18 expression vectors. 48 h after transfection, the cells were 
fi  xed with a solution containing 4% PFA, permeabilized with 1% Triton-
PBS, and stained with anti-STAT3 or anti-Flag, followed by treatment with 
the respective secondary antibody, Alexa Fluor 488–conjugated anti–mouse 
IgG (Invitrogen) or Alexa Fluor 594–conjugated anti–rabbit IgG anti-
body (Invitrogen). The immunostained cells were analyzed using a fl  uores-
cence microscope (IX71; Olympus). Nuclei were counterstained with 
4    ,6-diamidino-2-phenylindole (Wako Chemicals USA, Inc.). 
  Structural modeling.     Models of the kinase domains of RH  WT  , RH  L503S  , 
ME49  WT  , and ME49  S503L   were constructed from ff  as03 profi  le-profi  le align-
ments (http://ff  as.burnham.org/ff  as-cgi/cgi/ff  as.pl) using the PDB0709 and 
SCOP175 profi  le databases. The top PDB0709 and SCOP175 alignments 
(corresponding to templates 3cokA and d1s9ja, respectively) were selected 
for each of the three sequences, resulting in a total of six structural models. 
Structural models were built using Spanner (http://sysimm.ifrec.osaka-u
.ac.jp/cgi-bin/spanner), which employs a fragment assembly algorithm to 
produce a gapless alignment to the template. The structural models were 
then submitted to the SeSAW functional annotation server (http://sysimm
.ifrec.osaka-u.ac.jp/SeSAW/). SeSAW uses a combined structure and se-
quence profi  le–profi  le similarity score (  Standley et al., 2008  ) to rank their 
similarity to known structures. The model built on SCOP domain d1s9ja 
(dual-specifi  city mitogen-activated protein kinase kinase 1) resulted in sig-
nifi  cantly higher SeSAW scores than that built on PDB entry 3cokA (323.0 
and 253.0, respectively) so the d1s9ja model was ultimately retained for fur-
ther analysis. Residues 387–452 could not be modeled with as high a confi  -
dence as the rest of the structure as a result of a large insertion and were 
omitted from   Fig. 6   and Fig. S7. The predicted active site cavity location was 
based on that of d1s9ja dual-specifi  city MAP kinase kinase 1. Electrostatic 
surfaces were prepared using the eF-surf server (http://ef-site.hgc.jp/
eF-surf/) and eF-site (  Kinoshita and Nakamura, 2004  ). 
  Online supplemental material.     Fig. S1 shows defective time-dependent 
Stat3 activation in cells infected with ROP16-defi  ceint parasites. Fig. S2 
demonstrates cytoplasmic Stat3 localization in ROP18-transfected cells and 
activation of the Stat3-dependent promoter in cells transfected with NLS-
mutated ROP16. Fig. S3 exhibits complementation of ROP16-defi  cient 
parasites by ROP16 mutants. Fig. S4 shows amino acid sequences of type I 
and type II ROP16 at position 373–547. Fig. S5 demonstrates time-depen-
dent Stat3 activation in cells infected with ROP16-complemented parasites. 
Fig. S6 illustrates type I ROP16 deletion and point mutants used in this 
study. Fig. S7 shows in silico modeling of ROP16 variants and screening 2760 Direct Stat3 activation by   T. gondii   ROP16   | Yamamoto et al. 
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